RIGEL PHARMACEUTICALS INC (RIGL) Form 8-K — Jul 1, 2026
Rigel Pharmaceuticals announced a leadership transition within its medical department, effective June 25, 2026. Lisa Rojkjaer, M.D. departed from her role as Executive Vice President and Chief Medical Officer on that date. Alison L.
Price after filing
1 day: +1.1%7 days: +12.1%30 days: -0.6%
Close on the filing date to close N calendar days later (from $38.29). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.